What are the Long-Term Effects of Macrocyclic GBAs?
The long-term effects of macrocyclic GBAs are still a subject of ongoing research. Current data suggest that their retention in the body is significantly lower than that of linear GBAs. Nevertheless, concerns about gadolinium retention have prompted further studies to understand any potential long-term health implications fully. The FDA continues to monitor and evaluate these agents to ensure patient safety.
